A Phase I, Dose-Escalation Study to Assess the Safety and Drug Levels in Blood of AZD4877 in Japanese Adult Patients
NCT00613652
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Tumors
Carcinoma
Interventions
DRUG:
AZD4877
Sponsor
AstraZeneca